DiscoverClinical Perspective Roundtable Discussion
Clinical Perspective Roundtable Discussion
Claim Ownership

Clinical Perspective Roundtable Discussion

Author: Healio

Subscribed: 1Played: 5
Share

Description

Episode 1: Hear Davida Kruger, NP and Julio Rosenstock, MD
discuss important head-to-head data between a GLP-1 RA
and DPP-4 inhibitor as an important consideration when
making clinical decisions for patients with T2D.

Episode 2: Listen to the second part of this 3-part series where
two clinicians have an in-depth discussion about a head-to-head study comparing two oral antidiabetic therapies.

Episode 3: Hear this clinical panel share a quick overview of
the patient support resources available to help patients with
T2D get off to a successful start with this GLP-1 RA
treatment option.

This podcast is sponsored by Novo Nordisk Inc. and is
intended for clinicians.
3 Episodes
Reverse
Episode 3: Hear this clinical panel share a quick overview of the patient support resources available to help patients with T2D get off to a successful start with this GLP-1 RA treatment option. This podcast is sponsored by Novo Nordisk, Inc. and is intended for clinicians.
Episode 2: Listen to the second part of this 3-part series where two clinicians have an in-depth discussion about a head-to-head study comparing two leading oral antidiabetic. This podcast is sponsored by Novo Nordisk, Inc. and is intended for clinicians.
Episode 1: Hear Davida Kruger, NP and Julio Rosenstock, MD discuss important head-to-head data between a GLP-1 RA and DPP-4 inhibitor as an important consideration when making clinical decisions for patients with T2D. This podcast is sponsored by Novo Nordisk, Inc. and is intended for clinicians.
Comments